The board of Cryo-Cell International, Inc. (NYSEAM:CCEL) announced the Spin-Off of Celle Corp. to its shareholders on March 25, 2024. The board of Directors of Cryo-Cell International has authorized the spin-off of its newly formed subsidiary, Celle Corp., to the Cryo-Cell shareholders currently anticipated to be in the form of a stock dividend to the Cryo-Cell shareholders and to occur in Cryo-Cell?s 2nd or 3rd fiscal quarters.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.93 USD | +4.20% | +5.68% | +55.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.30% | 72.37M | |
+13.70% | 81.4B | |
-29.20% | 70.18B | |
+9.72% | 29.08B | |
-11.43% | 16.97B | |
-0.43% | 16.96B | |
-0.31% | 15.26B | |
+3.42% | 12.41B | |
-30.70% | 11.95B | |
-6.75% | 11.93B |
- Stock Market
- Equities
- CCEL Stock
- News Cryo-Cell International, Inc.
- Cryo-Cell International, Inc. agreed to Spin-Off Celle Corp.